Review
Immune evasion of SARS-CoV-2 from interferon antiviral system

https://doi.org/10.1016/j.csbj.2021.07.023Get rights and content
Under a Creative Commons license
open access

Abstract

The on-going pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to unprecedented medical and socioeconomic crises. Although the viral pathogenesis remains elusive, deficiency of effective antiviral interferon (IFN) responses upon SARS-CoV-2 infection has been recognized as a hallmark of COVID-19 contributing to the disease pathology and progress. Recently, multiple proteins encoded by SARS-CoV-2 have been shown to act as potential IFN antagonists with diverse possible mechanisms. Here, we summarize and discuss the strategies of SARS-CoV-2 for evasion of innate immunity (particularly the antiviral IFN responses), understanding of which will facilitate not only the elucidation of SARS-CoV-2 infection and pathogenesis but also the development of antiviral intervention therapies.

Keywords

SARS-CoV-2
COVID-19
Coronavirus
Interferon
Immune evasion
Innate immunity

Cited by (0)

1

Contributed equally to the work.